title: Cyclin-dependent kinase inhibitor 2A (p16) distinguishes well-differentiated liposarcoma from lipoma.
authors.forename: Raul S
authors.initials: RS
authors.lastname: Gonzalez
authors.forename: Colt M
authors.initials: CM
authors.lastname: McClain
authors.forename: Ben K
authors.initials: BK
authors.lastname: Chamberlain
authors.forename: Cheryl M
authors.initials: CM
authors.lastname: Coffin
authors.forename: Justin M M
authors.initials: JM
authors.lastname: Cates
mesh_terms: D014408:Biomarkers, Tumor / Q000378:metabolism*; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000378:metabolism*; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008067:Lipoma / Q000175:diagnosis* / Q000378:metabolism; D008080:Liposarcoma / Q000175:diagnosis* / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D012983:Soft Tissue Neoplasms / Q000175:diagnosis* / Q000378:metabolism
chemical_list: D014408:Biomarkers, Tumor; D019941:Cyclin-Dependent Kinase Inhibitor p16